Verisign Inc. (VRSN)
Buffett Is Still Buying, Plus Insiders Love These 2 Biotech Stocks
Much attention has been paid lately to the fact that Warren Buffett has been trimming stakes and building a cash hoard.
Warren Buffett is buying up stock in this old-school internet registry company
Warren Buffett has spent more than $70 million over six days to Dec. 24 to resume buying VeriSign's stock.
Warren Accuses Verisign of Web Domain Registration Monopoly
Sen. Elizabeth Warren is calling for an antitrust investigation into the web domain registration business. The Democratic lawmaker from Massachusetts — working with Rep.
Warren Accuses Verisign of Web Domain Registration Monopoly
Sen. Elizabeth Warren is calling for an antitrust investigation into the web domain registration business. The Democratic lawmaker from Massachusetts — working with Rep.
VeriSign: Q3 Doesn't Make It The Right Time To Buy
The Q3 report shows revenue up, high margins, EPS $2.07, but a decrease in the number of domain name registrations which makes the picture mixed. Despite a declining DNB, it still holds roughly 47% of the market in a very stable market position. Share buybacks continue to be a given, with management increasing shareholder benefits.
VeriSign, Inc. (VRSN) Q3 2024 Earnings Conference Call Transcript
VeriSign, Inc. (NASDAQ:VRSN ) Q3 2024 Earnings Conference Call October 24, 2024 4:30 PM ET Company Participants David Atchley - VP of IR and Corporate Treasurer Jim Bidzos - Executive Chairman, President and CEO George Kilguss - EVP and CFO Conference Call Participants Rob Oliver - Baird Max Moore - Citi Operator Good day, everyone. Welcome to VeriSign's Third Quarter 2024 Earnings Call.
VeriSign Q3 revenue rises on strong domain name demand
Internet services firm VeriSign reported a 3.8% rise in third-quarter revenue on Thursday, beating analyst expectations, driven by growing demand for domain name registration as businesses expand their online presence.
VeriSign Stock Vs. Gen Digital
Given its better prospects, we believe VeriSign stock (NASDAQ: VRSN), which provides domain name registry services and internet infrastructure, is a better pick than its industry peer, Gen Digital stock (NASDAQ: GEN), best known for its cyber safety products, including Norton, Avast, and AVG. Investors have assigned a higher valuation multiple of 12x revenues for VeriSign compared to 4.5x revenues for Gen Digital due to VeriSign's superior profitability and solid financial position.
VeriSign, Inc. (VRSN) Q2 2024 Earnings Call Transcript
VeriSign, Inc. (NASDAQ:VRSN ) Q2 2024 Earnings Conference Call July 25, 2024 4:30 PM ET Company Participants David Atchley - Vice President of Investor Relations & Corporate Treasurer Jim Bidzos - Executive Chairman, President & Chief Executive Officer George Kilguss - Executive Vice President & Chief Financial Officer Conference Call Participants Rob Oliver - Baird Ygal Arounian - Citigroup Operator Good day, everyone. Welcome to VeriSign's Second Quarter 2024 Earnings Call.
VeriSign: Underfollowed Value Opportunity Yielding A 9.8% Return
VeriSign stocks are undervalued by 20.1% and underfollowed by Wall Street analysts, indicating a potential mispricing. VeriSign boosts a monopolistic mature business model, with high operating margins and high free cash flow generation, compensating for modest growth. Despite recent stock price decline, VeriSign's risk-reward profile suggests a positive excess return of around 9.8%, with a catalyst expected after Q3 earnings report.
Will VeriSign Stock Recover To Its 2021 Highs Of Around $250?
VeriSign stock (NASDAQ: VRSN), a domain name provider, currently trades at $175 per share, around 30% below its peak level of $255 seen in December 2021. In comparison, its industry peer – F5 Networks stock (NASDAQ: FFIV), an application security and cloud networking company, also saw its stock decline by around 30% over the same period.
Warren Buffett Technology Guru? See The 4 Tech Stocks Where He Owns Millions of Shares
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
